| Literature DB >> 27536782 |
Su Jung Choi1,2, Sung Ik Lee3, Eun Yeon Joo1,4.
Abstract
To investigate the associations between amount of habitual alcohol consumption (HAC) and prevalence of metabolic syndrome (MetS), sleep, and sleep-disordered breathing (SDB). We enrolled 683 untreated SDB male patients (age: 54.4 ± 7.80 y, apnea-hypopnea index (AHI): 29.0 ± 21.53/h). HAC was assessed as the average number of drinks consumed per week during the past 12 months. Anthropometric and biochemical markers were used to diagnose MetS. Clinical data and MetS components were compared according to the reported amounts of HAC (no drinking, light drinking <13, heavy drinking ≥13 drinks/week). As reported, 78.9% of the participants (n = 539) were regular drinkers; 33.7% (n = 230) were habitually heavy drinkers (mean: 30.7 drinks/week), and 45.2% (n = 309) were light drinkers (5.1 drinks/week). The overall prevalence of MetS was 36.9% (n = 252) and was most common in heavy drinkers (40.5%). Compared to non-drinkers and light drinkers, heavy drinkers had the greatest body mass index (BMI) and waist circumference. Central obesity, hypertension, and hyperglycemia were most prevalent in heavy drinkers. Sleep quality and severity of SDB were the worst in heavy drinkers. After adjusting for age, AHI, and BMI, heavy drinkers had a 1.71 times greater risk of MetS when compared with non-drinkers, and light and heavy drinkers had a 2.06 and 2.11 times higher risk of severe SDB than non-drinkers. HAC may increase the prevalence of MetS and deteriorate sleep in relation to amount of alcohol intake. Even light drinkers had more than twice higher risk of severe SDB than non-drinkers.Entities:
Mesh:
Year: 2016 PMID: 27536782 PMCID: PMC4990257 DOI: 10.1371/journal.pone.0161276
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Characteristics of subjects with sleep disordered breathing according to habitual alcohol consumption.
| Non-drinkers (N = 144) | Light-drinkers (N = 309) | Heavy-drinkers (N = 230) | ||
|---|---|---|---|---|
| Age | 56.5±8.19 | 54.2±7.95 | 53.4±7.11 | 0.001 |
| Smoking | ||||
| ● Never smoking | 75(52.1) | 126(40.8) | 84(36.5) | 0.034 |
| ● Ex-smoker | 44(30.0) | 100(32.4) | 78(33.9) | |
| ● Current smoking | 26(18.1) | 83(26.9) | 68(29.6) | |
| Alcohol consumption, /week | 0 | 5.1±3.88 | 30.7±17.29 | <0.001 |
| Frequency of alcohol intake, /week | 0 | 1.4±1.02 | 3.3±1.47 | |
| ● <1/month | 7(2.3) | 0(0) | <0.001 | |
| ● 1/month | 18(5.8) | 0(0) | ||
| ● 2-4/month | 215(69.6) | 32(13.9) | ||
| ● 2-3/week | 63(20.4) | 132(57.4) | ||
| ● ≥4/week | 6(1.9) | 66(28.7) | ||
| Average intake/case | 0 | 3.9±2.47 | 10.4±5.72 | |
| ● <1 drink | 14(4.5) | 0(0) | <0.001 | |
| ● 1–2 drinks | 94(30.4) | 0(0) | ||
| ● 3–4 drinks | 93(30.1) | 2(2.2) | ||
| ● 5–6 drinks | 18(5.8) | 8(3.5) | ||
| ● ≥7 drinks | 90(29.1) | 217(94.3) | ||
| SBP, mmHg | 118.6±15.53 | 119.4±14.39 | 121.3±14.74 | 0.185 |
| DBP, mmHg | 75.4±9.90 | 76.5±9.70 | 79.2±10.12 | <0.001 |
| ● Waist circumference, cm | 90.6±9.09 | 89.9±7.18 | 91.7±7.92 | 0.038 |
| ● Body mass index, kg/m2 | 25.9±3.76 | 25.4±2.73 | 26.1±3.07 | 0.026 |
| ● Total cholesterol, mg/dL | 188.9±35.96 | 189.1±40.28 | 193.4±35.63 | 0.226 |
| ● LDL | 119.6±32.83 | 121.4±31.15 | 120.2±31.50 | 0.834 |
| ● HDL, mg/dL | 47.9±10.74 | 50.4±12.88 | 51.2±12.22 | 0.036 |
| ● Triglyceride, mg/dL | 141.8±92.48 | 142.8±84.51 | 163.5±111.23 | 0.028 |
| ● AST | 25.9±10.27 | 26.7±15.62 | 29.1±19.77 | 0.119 |
| ● ALT | 30.5±16.82 | 32.5±32.94 | 32.5±30.02 | 0.767 |
| ● GGT | 39.1±33.38 | 43.1±38.82 | 61.0±47.76 | <0.001 |
| ● Fibrinogen, mg/dL | 279.7±64.61 | 299.2±64.35 | 291.2±56.52 | 0.008 |
| ● Glucose, mg/dL | 100.8±22.47 | 100.8±20.08 | 104.7±17.13 | 0.050 |
| ● HbA1c, % | 5.8±0.91 | 5.7±0.76 | 5.8±0.73 | 0.304 |
| ● C-peptide, ng/mL | 2.2±1.31 | 2.2±0.99 | 2.5±1.00 | 0.019 |
| ● Insulin, uIU/mL | 8.9±4.68 | 8.7±5.01 | 9.4±5.66 | 0.335 |
| 50(34.7) | 100(32.4) | 102(44.3) | 0.014 | |
| ● Central obesity | 70(48.6) | 159(51.5) | 139(60.4) | 0.043 |
| ● Higher TG | 77(53.5) | 174(56.3) | 139(60.4) | 0.387 |
| ● HDL<40mg/dL | 29(20.1) | 65(21.0) | 42(18.3) | 0.725 |
| ● Hypertension | 80(55.6) | 194(62.8) | 157(68.3) | 0.046 |
| ● Hyperglycemia | 66(45.8) | 137(44.3) | 128(55.7) | 0.026 |
* ANOVA test
** Waist circumference ≥90cm
*** Triglyceride ≥150mg/dL or taking medication for dyslipidemia
† SBP≥130mmHg or DBP≥85mmHg or taking medication,
†† Fasting serum glucose≥100mg/dL or DM history or taking medication
SBP; systolic blood pressure, DBP; diastolic blood pressure, LDL; low-density lipoprotein, HDL; high-density lipoprotein, AST; aspartate transaminase, ALT; alanine transaminase, GGT; gamma glutamyl tranferase, HbA1c; hemoglobin
Fig 1Proportion of sleep-disordered breathing (SDB) severity according to habitual alcohol consumption (HAC).
The distribution of severity of SDB was significantly different according to HAC amount (X = 16.20, p = 0.003). The numbers of patients with severe SDB (apnea-hypopnea index ≥ 30/h) were the highest in heavy-drinkers. On the contrary, proportion of mild SDB was the greatest in non-drinkers.
Polysomnography-based sleep parameters according to habitual alcohol consumption.
| Non-drinkers (N = 144) | Light-drinkers (N = 309) | Heavy-drinkers (N = 230) | ||
|---|---|---|---|---|
| TST, min | 325.5±77.37 | 334.4±71.08 | 329.9±70.31 | 0.452 |
| SOL, min | 10.0±12.38 | 8.7±10.65 | 9.7±20.29 | 0.595 |
| REM latency | 98.6±56.01 | 96.3±53.41 | 96.0±64.92 | 0.906 |
| WASO,% | 15.9±10.16 | 15.2±10.24 | 15.2±9.07 | 0.733 |
| Sleep efficiency,% | 81.7±11.11 | 82.9±10.79 | 83.0±10.01 | 0.448 |
| ● N1 sleep | 24.2±11.71 | 24.8±12.42 | 27.3±12.82 | 0.025 |
| ● N2 sleep | 55.1±11.13 | 54.4±11.72 | 51.9±11.16 | 0.012 |
| ● N3 sleep | 2.5±4.38 | 2.3±3.99 | 1.8±3.70 | 0.218 |
| ● REM sleep | 18.1±6.93 | 18.4±6.99 | 18.9±7.04 | 0.543 |
| AHI, events/h | 25.5±24.31 | 28.2±20.19 | 32.2±21.07 | 0.009 |
| Nadir SaO2 | 82.8±7.35 | 82.3±6.68 | 81.1±7.44 | 0.045 |
| Arousal index, events/h | 30.1±13.75 | 31.7±15.09 | 34.5±17.03 | 0.019 |
| ● RAI | 17.3±16.33 | 20.4±16.88 | 23.1±18.20 | 0.007 |
| ● MAI | 1.4±3.77 | 1.2±3.08 | 0.9±2.22 | 0.220 |
| PLM index, events/h | 10.2±22.92 | 11.9±26.56 | 8.8±16.55 | 0.291 |
* TST; total sleep time, SOL; sleep onset latency, WASO; wake after sleep onset, REM; rapid eye movement, AHI; apnea-hypopnea index, SaO2; Oxygen saturation, RAI; respiratory arousal index, MAI; movement arousal index, PLM; periodic leg movement.
Odds ratio (95% Confidence Intervals) for metabolic syndrome according to habitual alcohol consumption.
| Unadjusted | Adjusted for age | Adjusted for age, and AHI | Adjusted for age, AHI, and BMI | |
|---|---|---|---|---|
| Non-drinkers | 1.0 (reference) | 1.0 (reference) | 1.0 (reference) | 1.0 (reference) |
| Light-drinkers | 0.90(0.59–1.37) | 0.91(0.60–1.34) | 0.87(0.57–1.34) | 1.13(0.68–1.88) |
| Heavy-drinkers | 1.50(0.97–2.30) | 1.52(0.98–2.35) | 1.38(0.88–2.15) | 1.71(1.01–2.88) |
AHI; apnea-hypopnea index, BMI; body mass index
Odds ratio (95% Confidence Intervals) for severe apnea-hypopnea index according to habitual alcohol consumption.
| Unadjusted | Adjusted for age | Adjusted for age, and BMI | |
|---|---|---|---|
| Non-drinkers | 1.0(reference) | 1.0(reference) | 1.0(reference) |
| Light-drinkers | 1.78(1.14–2.77) | 1.71(1.10–2.67) | 2.06(1.29–3.31) |
| Heavy-drinkers | 2.07(1.31–3.28) | 1.97(1.24–3.16) | 2.11(1.30–3.44) |
BMI; body mass index